Шрифт:
Интервал:
Закладка:
181
P. S. Dulai et al., “Systematic Review: The Safety and Efficacy of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease,” Alimentary Pharmacology & Therapeutics 39, no. 11 (June 2014): 1266-75.
182
David N. Teguh et al., “Early Hyperbaric Oxygen Therapy for Reducing Radiotherapy Side Effects: Early Results of a Randomized Trial in Oropharyngeal and Nasopharyngeal Cancer,” International Journal of Radiation Oncology, Biology, Physics 75, no. 3 (November 1, 2009): 711-16. Nico Schellart et al., “Hyperbaric Oxygen Treatment Improved Neurophysiologic Performance in Brain Tumor Patients after Neurosurgery and Radiotherapy: A Preliminary Report,” Cancer 117, no. 15 (August 1, 2011): 3434-44.
183
Daniel A. Rossignol et al., “The Effects of Hyperbaric Oxygen Therapy on Oxidative Stress, Inflammation, and Symptoms in Children with Autism: An Open-Label Pilot Study,” BMC Pediatrics 7, no. 36 (November 16, 2007). Daniel A. Rossignol et al., “Hyperbaric Treatment for Children with Autism: A Multicenter, Randomized, DoubleBlind, Controlled Trial,” BMC Pediatrics 9, no. 21 (March 13, 2009).
184
Arun Mukherjee et al., “Intensive Rehabilitation Combined with HBO2 Therapy in Children with Cerebral Palsy: A Controlled Longitudinal Study,” Undersea & Hyperbaric Medicine 41, no. 2 (March – April 2014): 77–85.
185
Claudio Borghi and Arrigo F. G. Cicero, “Nutraceuticals with a Clinically Detectable Blood Pressure-Lowering Effect: A Review of Available Randomized Clinical Trials and Their Meta-Analyses,” British Journal of Clinical Pharmacology 83, no. 1 (January 2017): 163-71.
186
Ameneh Mashayekh et al., “Effects of Ginkgo biloba on Cerebral Blood Flow Assessed by Quantitative MR Perfusion Imaging: A Pilot Study,” Neuroradiology 53, no. 3 (March 2011): 185-91. J. Kleijnen and P. Knipschild, “Ginkgo biloba for Cerebral Insufficiency,” British Journal of Clinical Pharmacology 34, no. 4 (October 1992): 352-58. F. Eckmann, “Cerebral Insufficiency – Treatment with Ginkgo-biloba Extract. Time of Onset of Effect in a Double-Blind Study with 60 Inpatients,” Fortschritte der Medizin 108, no. 29 (October 10, 1990): 557-60.
187
R. F. Santos et al., “Cognitive Performance, SPECT, and Blood Viscosity in Elderly NonDemented People Using Ginkgo biloba,” Pharmacopsychiatry 36, no. 4 (July 2003): 127-33. Joseph A. Mix and W. David Crews Jr., “A Double-Blind, Placebo-Controlled, Randomized Trial of Ginkgo biloba Extract EGb 761® in a Sample of Cognitively Intact Older Adults: Neuropsychological Findings,” Human Psychopharmacology 17, no. 6 (August 2002): 267-77.
188
Horst Herrschaft et al., “Ginkgo Biloba Extract EGb 761® in Dementia with Neuropsychiatric Features: A Randomised, Placebo-Controlled Trial to Confirm the Efficacy and Safety of a Daily Dose of 240 mg,” Journal of Psychiatric Research 46, no. 6 (June 2012): 716-23.
189
Chun-Xiao Dai et al., “Role of Ginkgo Biloba Extract as an Adjunctive Treatment of Elderly Patients with Depression and on the Expression of Serum S100B,” Medicine 97, no. 39 (September 2018): e12421.
190
Helmut Woelk et al., “Ginkgo Biloba Special Extract EGb 761® in Generalized Anxiety Disorder and Adjustment Disorder with Anxious Mood: A Randomized, Double-Blind, Placebo-Controlled Trial,” Journal of Psychiatric Research 41, no. 6 (September 2007): 472-80.
191
Daniel J. Lamport et al., “The Effect of Flavanol-Rich Cocoa on Cerebral Perfusion in Healthy Older Adults during Conscious Resting State: A Placebo Controlled, Crossover, Acute Trial,” Psychopharmacology 232, no. 17 (September 2015): 3227-34. David T. Field et al., “Consumption of Cocoa Flavanols Results in an Acute Improvement in Visual and Cognitive Functions,” Physiology & Behavior 103, nos. 3–4 (June 2011): 255-60. S. T. Francis et al., “The Effect of Flavanol-Rich Cocoa on the fMRI Response to a Cognitive Task in Healthy Young People,” Journal of Cardiovascular Pharmacology 47, suppl 2:S215-20 (June 2006). Farzaneh A. Sorond et al., “Neurovascular Coupling, Cerebral White Matter Integrity, and Response to Cocoa in Older People,” Neurology 81, no. 10 (September 3, 2013): 904-9.
192
Karin Ried et al., “Effect of Cocoa on Blood Pressure,” Cochrane Database of Systematic Reviews 8 (August 15, 2012): CD008893. Karin Ried et al., “Does Chocolate Reduce Blood Pressure? A Meta-Analysis,” BMC Medicine 8, no. 39 (June 28, 2010).
193
Giovambattista Desideri et al., “Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance through Cocoa Flavanol Consumption in Elderly Subjects with Mild Cognitive Impairment: The Cocoa, Cognition, and Aging (CoCoA) Study,” Hypertension 60, no. 3 (September 2012): 794–801. Daniela Mastroiacovo et al., “Cocoa Flavanol Consumption Improves Cognitive Function, Blood Pressure Control, and Metabolic Profile in Elderly Subjects: The Cocoa, Cognition, and Aging (CoCoA) Study – A Randomized Controlled Trial,” American Journal of Clinical Nutrition 101, no. 3 (March 2015): 538-48.
194
Davide Grassi et al., “Flavanol-Rich Chocolate Acutely Improves Arterial Function and Working Memory Performance Counteracting the Effects of Sleep Deprivation in Healthy Individuals,” Journal of Hypertension 34, no. 7 (July 2016): 1298–1308.
195
Mandy Oaklander, “5 Surprising Ways to Help Your Memory,” Time (June 10, 2015), http://time.com/3915030/boost-memory-exercise/. Philippa A. Jackson et al., “DHA-Rich Oil Modulates the Cerebral Haemodynamic Response to Cognitive Tasks in Healthy Young Adults: A Near IR Spectroscopy Pilot Study,” British Journal of Nutrition 107, no. 8 (April 28, 2012): 1093-98. Tae-Jin Song et al., “Low Levels of Plasma Omega 3-Polyunsaturated Fatty Acids Are Associated with Cerebral Small Vessel Diseases in Acute Ischemic Stroke Patients,” Nutrition Research 35, no. 5 (May 2015): 368-74.
196
A. Veronica Witte et al., “Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults,” Cerebral Cortex 24, no. 11 (November 2014): 3059-68.
197
E. L. Boespflug et al., “Fish Oil Supplementation Increases